[dr Deana B. Andric]

Hemijski fakultet, Studentski trg 12-16, Beograd
Katedra za organsku hemiju

Telefon:   011-3336759

Telefon (lokalni):   759

Kabinet:   476

Laboratorija:   463

E-mail:   deanad@chem.bg.ac.rs

Lični podaci

Datum i mesto rođenja: 20. 1. 1963, Beograd. Udata. Jezici koje koristi: srpski (maternji) i engleski.

Obrazovanje i usavršavanja

1981-1987: Osnovne studije - Hemijske nauke / Prirodno-matematički fakultet (Beograd)

1987-1991: Magistratura - Hemijske nauke / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

1992-1996: Doktorat - Hemijske nauke / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

Kretanje u službi

1999-2010: Docent / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

2010: Vanredni profesor / Univerzitet u Beogradu - Hemijski fakultet (Beograd)

Oblasti naučnog interesovanja

Medicinska hemija - sinteza i ispitivanje dopaminergičke i serotonergičke aktivnosti sintetisanih liganada i kompjutersko modelovanje interakcija ligand-receptor

Ostale aktivnosti

Član Srpskog hemijskog društva od 1. 1. 1989. - Sekcija za medicinsku hemiju; Sekcija za organsku hemiju.

Prodekan za finansije Hemijskog fakulteta od 19. 5. 2007. do 19. 5. 2010.

Predsednik Komisije za disciplinsku odgovornost studenata od 12. 7. 2021.

Angažman u nastavi

Učešće u naučnoistraživačkim projektima

Završeni projekti:

  • 2011: Proučavanje odnosa strukture i aktivnosti novosintetisanih biološki aktivnih supstanci – 172032
    vrsta projekta:   domaći fundamentalni
    projekat finansira:   Ministarstvo za nauku i tehnološki razvoj Republike Srbije (Beograd)

Brojevi za identifikaciju autora

Izabrane reference

Knjige i revijalni radovi / Books and reviews:

  1. Prof. dr Danica Katanić, doc. dr Deana Dragović, asis. mr Iris Đorđević: Praktikum iz hemije sa računskim zadacima, /Fakultet veterinarske medicine, Univerzitet u Beogradu, Beograd 1999./
  2. Dr Deana Andrić, dr Goran Roglić: Radni listovi iz organske hemije/Hemijski fakultet Univerzitet u Beogradu, Beograd 2010./

Izabrani radovi / Selected papers:

  1. Roglić, Goran; Andrić, Deana; Kostić-Rajačić, Slađana; Dukić, Slađana; Šoškić, Vukić: Introduction of a methyl group in α- or β- position of 1-heteroarylethyl-4-phenylpiperazines affects their dopaminergic/serotonergic properties. Arch. Pharm. (2001), 334, 373-378.
  2. Roglić Goran; Dukić-Stefanović, Slađana; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić: Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines. Pharmazie (2001), 56, 803-807.
  3. Šukalović, Vladimir; Roglić, Goran; Husinec, Suren; Kostić-Rajačić, Slađana; Andrić, Deana; Šoškić, Vukić: D2 dopaminergic 5HT1A serotonergic activity of 2-(1-naphtyl)ethyl- and 2-(2-naphtyl)ethyl amines. Arch. Pharm. (2003), 336, 514-522.
  4. Tomić, Mirko; Kundaković, Marija; Butorović, Biljana; Vasilev, Vesna; Dragović, Deana; Roglić, Goran; Ignjatović, Đurđica; Šoškić, Vukić; Kostić-Rajačić, Slađana: Pharmacological evaluation of 5-(2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl)-1,3-dihydro-benzimidazole-2-thione as a potential atypical antipsychotic agent. Pharmazie (2003), 58, 677-678.
  5. Šukalović, Vladimir; Andrić, Deana; Kostić Rajačić, Slađana; Roglić Goran; Šoškić, Vukić: Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands. Arch. Pharm. (2004), 337, 376-382.
  6. Šukalović, Vladimir; Zlatović Mario; Andrić, Deana; Kostić-Rajačić, Slađana; Roglić, Goran; Šoškić, Vukić: Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-(2-[5-(1/H/-benzimidazole-2-thione)]ethyl)-4-arylpiperazines. Arch. Pharm. (2004), 337, 502-512.
  7. Veličković, Jelena; Andrić, Deana; Roglić, Goran; Tešić, Živoslav; Milojković-Opsenica, Dušanka: Planar chromatography of some 1-arylpiperazines behaving as dopaminergic ligands. JPC-J. Planar. Chromat. (2004), 17, 255-260.
  8. Tomić, Mirko; Kundaković, Marija; Butorović, Biljana; Janać, Branka; Andrić, Deana; Roglić, Goran; Ignjatović, Đurđica; Kostić-Rajačić, Slađana: Pharmacological evaluation of selected arylpiperazines with atypicalantipsychotic potential. Bioorg. Med. Chem. Lett. (2004), 14, 4263-4266.
  9. Šukalović, Vladimir; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana; Schrattenholz, Andreas; Šoškić, Vukić: Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-3-(4-arylpiperazin-1-yl)propyl-1H-benzimidazole, 5-2-(4-arylpiperazin-1-yl)ethoxy-1H-benzimidazole and their analogues. Eur. J. Med. Chem. (2005), 40, 481-493.
  10. Šukalović, Vladimir; Zlatović Mario; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana; Šoškić, Vukić: Interaction of arylpiperazines with the D2 dopamine receptor binding site. Arzneimittel-Forsch./Drug Res. (2005), 55, 145-152.
  11. Zlatović Mario; Šukalović, Vladimir; Kostić-Rajačić, Slađana; Andrić, Deana; Roglić, Goran: Influence of N-1 substituent properties on binding affinities of arylpiperazines to the binding site of 5-HT1A receptor. J.Serb.Chem.Soc. (2006), 71(11), 1125-1135.
  12. Andrić, Deana; Tovilović, Gordana; Roglić, Goran; Vasković, Đurđica; Šoškić, Vukić; Tomić, Mirko; Kostić-Rajačić, Slađana: Synthesis and pharmacological evaluation of several N-(2-nitrophenyl)piperazine derivatives. J.Serb.Chem.Soc. (2007),72(5), 429-435.
  13. Andrić, Deana; Tovilović, Gordana; Roglić, Goran; Šoškić, Vukić, Tomić, Mirko; Kostić-Rajačić, Slađana: 6-[2-(4-Arylpiperazin-1-yl)ethyl]-4-halo-1,3-dihydro-2H-benzimidazole-2-thiones: synthesis and pharmacological evaluation. J.Serb.Chem.Soc. (2007), 72(8-9), 747-755.
  14. Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić; Roglić, Goran: 1-Cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D2) and serotonin (5-HT1A) receptors. Arch. Pharm. Chem. Life Sci. (2007), 340, 456-465.
  15. Tomić, Mirko; Ignjatović, Đurđica; Tovilović, Gordana; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Two new phenylpiperazines with atypical antipsychotic potential. Bioorg. Med. Chem. Lett. (2007), 17, 5749-5753.
  16. Andrić, Deana; Roglić, Goran; Šukalović, Vladimir; Šoškić, Vukić; Kostić-Rajačić, Slađana: Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2- and 5-HT1A receptors. Eur. J. Med. Chem. (2008), 43, 1696-1705.
  17. Šukalović, Vladimir; Zlatović, Mario; Roglić, Goran; Kostić-Rajačić, Slađana; Andrić, Deana: Application of hybrid density functional theory in calculation edge-to-face interactions of receptor-ligand system. Acta. Chim. Slov. (2009), 56, 270-277.
  18. Trfković, Jelena; Andrić, Filip; Ristivojević, P.; Andrić, Deana; Tešić, Živoslav; Milojković-Opsenica, Dušanka: Structure-retention relationship studz of arylpiperazines by linear multivariate modeling. J. Sep. Sci. (2010), 33, 2619-2628.
  19. Tomić, Mirko; Vasković, Đurđica; Tovilović, Gordana; Andrić, Deana; Penjišević, Jelena; Kostić-Rajačić, Slađana: Pharmacological evaluation of halogenated and non-halogenated arylpiperazin-1-yl-ethyl-benzimidazoles as D2 and 5-HT2A receptor ligands. Arch. Pharm. Chem. Life Sci. (2011), 344(5), 287-291.
  20. Senćanski, Milan; Šukalović, Vladimir; Došen-Mićović, Ljiljana; Šoškić, Vukić; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Modeling interactions of alpha (1a) adenergic receptor and different arylpiperazine ligands. Dig. J. Nanomater. Bios. (2012), 7(4), 1767-1777.
  21. Šukalović, Vladimir; Ignjatović, Đurđica; Tovilović, Gordana; Andrić, Deana; Shakib, K.; Kostić-Rajačić, Slađana; Vukić, Šoškić: Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxyltryptamine 5HT1A receptors. Bioorg. Med. Chem. Lett. (2012), 22(12), 3967-3972.
  22. Ignjatović, Đurđica; Vojnović Milutinović, D.; Nikolić-Kokić, A.; Slavić, M.; Andrić, Deana; Tomić, Mirko; Kostić-Rajačić, Slađana: The mechanisms responsible for neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside. Eur. J. Pharmacol. (2012), 683, 93-100.
  23. Šulalović, Vladimir; Šoškić, Vukić; Andrić, Deana, Roglić, Goran; Kostić-Rajačić, Slađana: Modeling key interactions between dopamine D2 receptor second extracellular loop and arylpiperazine ligands. J. Serb. Chem. Soc. (2012), 77(3), 259-277.
  24. Novaković, Irena; Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Investigation of antibacterial activity of cinnamyl derivates of arylpiperazine. Arch. Biol. Sci. (2012), 64(1), 15-20.
  25. Šukalović, Vladimir; Bogdan, A.E.; Tovilović, Gordana; Ignjatović, Đurđica; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić: N-{[2-(4-Phenyl-piperazin-1-yl)-ethyl]-phenyl}-arylamides with dopamine D2 and 5-hydroxytryptamine 5HT1A activity: synthesis, testing and molecular modeling. Arch. Pharm. Chem. Life Sci. (2013), 346, 708-717.
  26. Šukalović, Vladimir; Šiškić, Vukić; Senćanski, Milan; Andrić, Deana; Kostić-Rajačić, Slađana: Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model. J. Mol. Model. (2013), 19(4), 1751-1762.
  27. Vasić, Vesna; Penjišević, Jelena; Novaković, Irena; Šukalović, Vladimir; Andrić, Deana; Kostić-Rajačić, Slađana: Synthesis and biological evaluation of 5-substituted derivatives of benzimidazole. J. Serb. Chem. Soc. (2014), 79(3), 277-282.
  28. Šukalović, Vladimir; Šoškić, Vukić; Ignjatović, Đurđica; Andrić, Deana; Penjišević, Jelena; Kostić-Rajačić, Slađana: Investigation of key interactions between the second extracellular loop of the dopamine D2 receptor and several hydroxy-N-{[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}-nicotinamides. J. Serb. Chem. Soc. (2014), 79(12), 1461-1467.